Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Topical spironolactone effectively treats hair loss in women.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Minoxidil may help treat hair loss by reducing inflammation-related gene activity in skin cells.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Five molecular elements identified as potential future targets for hair loss therapy.

Clomiphene citrate improves fertility in men taking finasteride for hair loss.

Women over forty can maintain skin and hair health with lifestyle and dietary changes.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Female hair loss patients more likely to have dry eye and gland issues.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Early hair loss may indicate risk of insulin resistance.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The paper suggests that hair loss might be caused by skull growth, not just DHT's effect on hair follicles, and calls for more research.